tiprankstipranks
Trending News
More News >
Cipher Pharmaceuticals (TSE:CPH)
TSX:CPH
Canadian Market

Cipher Pharmaceuticals (CPH) Ratios

Compare
90 Followers

Cipher Pharmaceuticals Ratios

TSE:CPH's free cash flow for Q3 2025 was $0.82. For the 2025 fiscal year, TSE:CPH's free cash flow was decreased by $ and operating cash flow was $0.39. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
1.30 1.94 9.19 4.07 2.39
Quick Ratio
0.98 1.64 8.62 3.84 2.25
Cash Ratio
0.41 0.90 7.58 3.08 1.67
Solvency Ratio
0.72 0.26 3.92 2.85 0.66
Operating Cash Flow Ratio
1.46 0.98 3.05 1.13 1.12
Short-Term Operating Cash Flow Coverage
0.00 0.00 0.00 0.00 0.00
Net Current Asset Value
$ -6.91M$ -21.68M$ 42.76M$ 28.46M$ 16.57M
Leverage Ratios
Debt-to-Assets Ratio
0.09 0.25 <0.01 <0.01 <0.01
Debt-to-Equity Ratio
0.12 0.40 <0.01 <0.01 0.01
Debt-to-Capital Ratio
0.11 0.28 <0.01 <0.01 0.01
Long-Term Debt-to-Capital Ratio
0.10 0.28 0.00 0.00 0.00
Financial Leverage Ratio
1.29 1.59 1.07 1.15 1.33
Debt Service Coverage Ratio
20.14 0.00 0.00 58.42 112.59
Interest Coverage Ratio
9.40 0.00 0.00 23.89 128.49
Debt to Market Cap
0.05 0.16 0.00 0.00 0.00
Interest Debt Per Share
0.58 1.64 0.01 <0.01 0.02
Net Debt to EBITDA
0.25 1.92 -3.42 -2.36 -1.47
Profitability Margins
Gross Profit Margin
74.32%72.24%80.77%80.69%83.21%
EBIT Margin
25.52%23.52%48.68%53.45%59.51%
EBITDA Margin
39.38%35.56%54.48%57.80%62.25%
Operating Profit Margin
25.52%23.52%54.48%53.62%53.87%
Pretax Profit Margin
19.37%8.86%59.92%55.52%50.40%
Net Profit Margin
34.69%34.60%96.32%128.83%35.36%
Continuous Operations Profit Margin
34.69%34.60%96.32%128.83%35.36%
Net Income Per EBT
179.06%390.69%160.74%232.04%70.15%
EBT Per EBIT
75.91%37.65%109.99%103.55%93.55%
Return on Assets (ROA)
11.77%7.10%23.69%36.10%15.02%
Return on Equity (ROE)
16.11%11.28%25.31%41.57%19.94%
Return on Capital Employed (ROCE)
10.05%5.50%14.27%18.69%30.04%
Return on Invested Capital (ROIC)
10.03%5.49%14.26%18.66%21.04%
Return on Tangible Assets
30.78%17.41%29.73%48.15%24.02%
Earnings Yield
6.35%4.69%19.15%37.41%20.84%
Efficiency Ratios
Receivables Turnover
4.94 2.41 4.16 3.04 3.30
Payables Turnover
3.11 1.58 0.88 0.97 0.66
Inventory Turnover
1.92 1.60 1.36 1.86 2.23
Fixed Asset Turnover
110.50 49.06 52.64 42.98 43.80
Asset Turnover
0.34 0.21 0.25 0.28 0.42
Working Capital Turnover Ratio
5.26 1.08 0.59 0.90 1.61
Cash Conversion Cycle
147.15 148.44 -60.88 -58.67 -276.15
Days of Sales Outstanding
73.83 151.63 87.76 120.08 110.75
Days of Inventory Outstanding
190.54 228.30 267.49 196.76 163.48
Days of Payables Outstanding
117.22 231.50 416.13 375.51 550.37
Operating Cycle
264.37 379.93 355.25 316.85 274.23
Cash Flow Ratios
Operating Cash Flow Per Share
1.18 0.79 0.63 0.10 0.52
Free Cash Flow Per Share
1.17 0.79 0.63 0.10 0.52
CapEx Per Share
<0.01 <0.01 <0.01 <0.01 0.00
Free Cash Flow to Operating Cash Flow
1.00 1.00 1.00 0.99 1.00
Dividend Paid and CapEx Coverage Ratio
332.03 444.23 111.10 130.56 0.00
Capital Expenditure Coverage Ratio
332.03 444.23 111.10 130.56 0.00
Operating Cash Flow Coverage Ratio
2.23 0.48 45.32 24.71 26.77
Operating Cash Flow to Sales Ratio
0.60 0.59 0.76 0.51 0.63
Free Cash Flow Yield
10.90%7.93%15.01%14.74%37.11%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
15.75 21.31 5.22 11.43 4.80
Price-to-Sales (P/S) Ratio
5.46 7.37 5.03 14.73 1.70
Price-to-Book (P/B) Ratio
2.40 2.40 1.32 4.75 0.96
Price-to-Free Cash Flow (P/FCF) Ratio
9.18 12.61 6.66 29.01 2.69
Price-to-Operating Cash Flow Ratio
9.15 12.59 6.65 28.79 2.69
Price-to-Earnings Growth (PEG) Ratio
0.35 -0.52 0.02 -0.83 0.07
Price-to-Fair Value
2.40 2.40 1.32 4.75 0.96
Enterprise Value Multiple
14.12 22.65 5.81 23.10 1.26
Enterprise Value
278.36M 268.74M 66.94M 42.79M 17.19M
EV to EBITDA
14.12 22.65 5.81 3.55 1.26
EV to Sales
5.56 8.05 3.16 2.07 0.78
EV to Free Cash Flow
9.34 13.78 4.19 4.08 1.24
EV to Operating Cash Flow
9.32 13.75 4.18 4.05 1.24
Tangible Book Value Per Share
0.90 0.25 2.47 0.42 0.73
Shareholders’ Equity Per Share
4.49 4.14 3.16 0.60 1.46
Tax and Other Ratios
Effective Tax Rate
-0.79 -2.91 -0.61 -1.32 0.30
Revenue Per Share
1.97 1.35 0.83 0.19 0.82
Net Income Per Share
0.68 0.47 0.80 0.25 0.29
Tax Burden
1.79 3.91 1.61 2.32 0.70
Interest Burden
0.76 0.38 1.23 1.04 0.85
Research & Development to Revenue
<0.01 0.00 <0.01 <0.01 <0.01
SG&A to Revenue
0.31 0.32 0.22 0.19 0.00
Stock-Based Compensation to Revenue
0.03 0.03 0.06 0.02 <0.01
Income Quality
1.72 1.69 0.78 0.40 1.78
Currency in USD